Clinical T2N0M0 Esophageal Cancer-Is Treatment Pathway Associated With Overall Survival?

Ma, Wanyan; Nuckles, Brandon; Frank, Katie; Young, Katelyn A; Hoffman, Rebecca L; Blansfield, Joseph A

Ma, Wanyan; Nuckles, Brandon; Frank, Katie; Young, Katelyn A; Hoffman, Rebecca L; Blansfield, Joseph A.

Afiliação

Ma W; Geisinger Department of General Surgery, Danville, Pennsylvania. Electronic address: wma@geisinger.edu.
Nuckles B; Geisinger Department of General Surgery, Danville, Pennsylvania.
Frank K; Geisinger Department of General Surgery, Danville, Pennsylvania.
Young KA; Geisinger Department of General Surgery, Danville, Pennsylvania.
Hoffman RL; Geisinger Department of General Surgery, Danville, Pennsylvania.
Blansfield JA; Geisinger Department of General Surgery, Danville, Pennsylvania.

J Surg Res ; 283: 205-216, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36410237

Assuntos

Neoplasias Esofágicas; Humanos; Estudos Retrospectivos; Estadiamento de Neoplasias; Neoplasias Esofágicas/patologia; Terapia Combinada; Terapia Neoadjuvante; Esofagectomia; Resultado do Tratamento; Taxa de Sobrevida; Quimiorradioterapia Adjuvante

Palavras-chave

CROSS trial; Esophageal cancer; Esophagectomy; Multimodal therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Surg Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google